Media Center

In a victory for Members of Congress, Judge Emmet Sullivan of the U.S. District Court for the District of Columbia has now denied, in full, President Trump's motion to dismiss the challenge brought by roughly 200 Members of the Senate and House of Representatives, to hold him accountable to the Constitution's Foreign Emoluments Clause. On learning this news, the lead plaintiffs and their counsel issued the following statement:

Today, House Judiciary Committee Chairman Jerrold Nadler released a statement in response to reports that Special Counsel Robert Mueller wrote to Attorney General William Barr last month to object to the Attorney General's summary of his report:

Washington, D.C. - Reps. Jerrold Nadler (D-N.Y.), Chairman of the House Judiciary Committee and Doug Collins (R-Ga.), Ranking Member of the House Judiciary Committee, today introduced the Prescription Pricing for the People Act of 2019. The legislation requires the Federal Trade Commission (FTC) to study pharmacy benefits managers (PBMs) and how their actions are affecting patients and local pharmacies. The legislation will be marked up in the House Judiciary Committee on April 30, 2019.

On April 30, 2019 at 2pm, the House Judiciary Committee will consider four bills to address prescription drug pricing, including H.R. 965, the CREATES Act; H.R. 2375, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 2374, the Stop STALLING Act; and H.R. 2376, the Prescription Pricing for the People Act of 2019.

Date: April 30, 2019

Time: 2:00 p.m.

Location: 2141 Rayburn House Office Building

Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) and Ranking Member Doug Collins (R-GA) introduced H.R. 2375, the bipartisan Preserve Access to Affordable Generics and Biosimilars Act. This legislation strengthens the Federal Trade Commission's (FTC) ability to challenge settlement agreements between large brand drug companies and generic drug companies in court, which will help lower prescription drug prices for Americans. The legislation will be marked up in the House Judiciary Committee on April 30, 2019.

Washington, D.C. (Apr. 25, 2019)-Today, Rep. Elijah E. Cummings, the Chairman of the Committee on Oversight and Reform, Rep. Jerrold Nadler, the Chairman of the Committee on the Judiciary, and Rep. Bennie G.

On May 2, 2019 at 9:00 a.m., the House Judiciary Committee will hold an oversight hearing with Attorney General William Barr regarding Special Counsel Robert Mueller's report and related matters.

Witness: Attorney General William Barr, U.S. Department of Justice

Date: May 2, 2019

Time: 9:00 a.m.

Location: 2141 Rayburn House Office Building

Washington D.C.